Phagocytosis of Astaxanthin-Loaded Microparticles Modulates TGFβ Production and Intracellular ROS Levels in J774A.1 Macrophages.
Eleonora BinattiGianni ZoccatelliFrancesca ZanoniGiulia DonàFederica MainenteRoberto ChignolaPublished in: Marine drugs (2021)
Radiation-induced fibrosis is a serious long-lasting side effect of radiation therapy. Central to this condition is the role of macrophages that, activated by radiation-induced reactive oxygen species and tissue cell damage, produce pro-inflammatory cytokines, such as transforming growth factor beta (TGFβ). This, in turn, recruits fibroblasts at the site of the lesion that initiates fibrosis. We investigated whether astaxanthin, an antioxidant molecule extracted from marine and freshwater organisms, could help control macrophage activation. To this purpose, we encapsulated food-grade astaxanthin from Haematococcus pluvialis into micrometer-sized whey protein particles to specifically target macrophages that can uptake material within this size range by phagocytosis. The data show that astaxanthin-loaded microparticles are resistant to radiation, are well-tolerated by J774A.1 macrophages, induce in these cells a significant reduction of intracellular reactive oxygen species and inhibit the release of active TGFβ as evaluated in a bioassay with transformed MFB-F11 fibroblasts. Micro-encapsulation of bioactive molecules is a promising strategy to specifically target phagocytic cells and modulate their own functions.
Keyphrases
- radiation induced
- reactive oxygen species
- transforming growth factor
- radiation therapy
- epithelial mesenchymal transition
- induced apoptosis
- drug delivery
- oxidative stress
- cell cycle arrest
- signaling pathway
- adipose tissue
- dna damage
- anti inflammatory
- single cell
- squamous cell carcinoma
- endoplasmic reticulum stress
- cancer therapy
- stem cells
- locally advanced
- extracellular matrix
- cell therapy
- rectal cancer
- high resolution
- wound healing
- cell death
- sensitive detection
- pi k akt
- bone marrow
- human health
- multidrug resistant
- mesenchymal stem cells